Stephan A. Grupp

Children's Hospital of Philadelphia — United States

Medicine · Health Sciences

103h-index61.7kcitations801works10.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(425), Acute Lymphoblastic Leukemia research(200), Hematopoietic Stem Cell Transplantation(124), Neuroblastoma Research and Treatments(93), Virus-based gene therapy research(87)

Publications799 total

CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multi-site, retrospective cohort review
Blood Advances·2026Open Access
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia
Blood Advances·2026Open Access
Pharmacokinetically-Adjusted Busulfan Dosing in Adults and Adolescents with Sickle Cell Disease or Transfusion-Dependent β-Thalassemia Treated with Exagamglogene Autotemcel
Transplantation and Cellular Therapy·2026
Operational and Data Quality Alerting in a Cell Therapy Laboratory
Transplantation and Cellular Therapy·2026
Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide
Transplantation and Cellular Therapy·2026
CD19 CAR T-cell Therapy in Infant B-ALL: Durable Remissions, Relapse Patterns, and Molecular Correlates
Transplantation and Cellular Therapy·2026
Multi-Week Forecasting of Pediatric BMT Census: Deployment and Operationalization
Transplantation and Cellular Therapy·2026
Durable Clinical Benefits with Exagamglogene Autotemcel for over 5 Years of Follow-up in Transfusion-Dependent Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises
Transplantation and Cellular Therapy·2026
Next Generation Sequencing Minimal Residual Disease in Pediatric B-ALL after CD19 and/or CD22 CAR T-cell Therapy: Depth and Kinetics of Response Predict Relapse Risk.
Transplantation and Cellular Therapy·2026
High Rates of Clinically Significant Late Infections and Recurrent Sinopulmonary Disease in Long-Term Survivors after CD19 CAR T-cell Therapy for Pediatric B-ALL
Transplantation and Cellular Therapy·2026
Comment on Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers
Transplantation and Cellular Therapy·2026
Supplementary Table S1 from D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
2025Open Access
Supplementary Figure S5 from D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
2025Open Access
Supplementary Figure S8 from D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
2025Open Access
Supplementary Figure S4 from D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
2025Open Access
Supplementary Figure S3 from D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
2025Open Access
Supplementary Table S2 from D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
2025Open Access
Supplementary Figure S7 from D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
2025Open Access
Supplementary Figure S6 from D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
2025Open Access
Supplementary Figure S2 from D3-GPC2–Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer
2025Open Access
page 1 of 40Next →

Frequent Co-authors

Carl H. June(20), Shannon L. Maude(19), David T. Teachey(14), David L. Porter(13), David M. Barrett(12), Bruce L. Levine(10), Simon F. Lacey(10), Noelle V. Frey(9), J. Joseph Melenhorst(8), Michael Kalos(7), David M. Barrett(6), Saar Gill(6), Patricia A. Wood(5), Michael A. Pulsipher(5), Pamela A. Shaw(5), Richard Aplenc(5), Michael C. Milone(5), Marco Ruella(5), Julie C. Fitzgerald(5), Theodore W. Laetsch(4)